CLOPOXIDE |
TRAKIPEAL |
CHLORDIAZACHEL |
ZEISIN |
LYGEN |
LIBRITABS |
SARLIB |
CHLORDIAZEPOXIDE CIV |
LIBRELEASE |
A-POXIDE |
LIBRIUM |
CHLORDIAZEPOXIDE |
CHLORADIAZEPOXIDE |
METHAMINODIAZEPOXIDE |
CHLORDIAZEPOXIDE BASE |
CDP |
7-CHLORO-2-METHYLAMINO-5-PHENYL-3H-1,4-BENZODIAZEPIN-4-OXIDE |
CHLORDIAZEPOXIDUM |
chembl:CHEMBL451 |
chemidplus:58-25-3 |
drugbank:00475 |
pubchem.compound:2712 |
rxcui:2356 |
Year of Approval | approved before 1982 |
Drug Class | hypnotics and sedatives |
FDA Approval | Approved before 1982 |
Drug Class | small molecule |
Drug Indications | Hypnotics and Sedatives |
n/a |
Trial Name | - |
Novel drug target | Established target |
n/a |
Trial Name | - |
Novel drug target | Established target |
n/a |
Trial Name | - |
Novel drug target | Established target |
ligand |
positive modulator (activating) |
Trial Name | - |
Novel drug target | Established target |
Direct Interaction | yes |
positive modulator (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
positive modulator (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Trial Name | - |
positive modulator (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Novel drug target | Established target |
Trial Name | - |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Trial Name | - |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
positive modulator (activating) |
Novel drug target | Established target |
Trial Name | - |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Trial Name | - |
positive modulator (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
CHLORDIAZEPOXIDE | Primary Drug Name |
Drug Class | hypnotics and sedatives |
Year of Approval | approved before 1982 |
Drug Indications | Hypnotics and Sedatives |
Drug Class | small molecule |
FDA Approval | Approved before 1982 |
CHEMBL451 | ChEMBL Drug ID |
D06BEP | TTD Drug ID |